Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study. Kuruvilla J, Armand P, Hamadani M, Kline J, et al. Leuk Lymphoma 2022 Nov 18:1-10. doi: 10.1080/10428194.2022.2136956.

Read + Share

Amedeo Smart

Independent Medical Education

Kuruvilla J, Armand P, Hamadani M, Kline J, et al. Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study. Leuk Lymphoma 2022 Nov 18:1-10. doi: 10.1080/10428194.2022.2136956.
PMID: 36398795